Celldex Therapeutics (CLDX) Amortizatization of Intangibles (2010 - 2026)

Celldex Therapeutics' Amortizatization of Intangibles history runs 17 years deep, the most recent figure standing at $630000.0 for Q1 2026.

• In Q1 2026, Amortizatization of Intangibles fell 72.21% year-over-year to $630000.0; the TTM figure through Mar 2026 stood at $4.2 million (down 71.31% YoY), while the FY2025 annual figure was $5.9 million, down 62.82% from the prior year.
• Amortizatization of Intangibles was $630000.0 for Q1 2026 at Celldex Therapeutics, down from $882000.0 in the prior quarter.
• In the past five years, Amortizatization of Intangibles ranged from a high of $4.7 million in Q2 2024 to a low of -$772000.0 in Q1 2022.
• Historically, Amortizatization of Intangibles has averaged $1.6 million across 5 years, with a median of $1.3 million in 2023.
• The sharpest annual moves came in 2022 and 2023: Amortizatization of Intangibles slumped 1708.33% in 2022, then jumped 2905.17% in 2023.
• A 5-year view of Amortizatization of Intangibles shows it stood at $522000.0 in 2022, then jumped by 317.43% to $2.2 million in 2023, then surged by 54.34% to $3.4 million in 2024, then sank by 73.77% to $882000.0 in 2025, then decreased by 28.57% to $630000.0 in 2026.
• The last three Amortizatization of Intangibles figures came in at $630000.0 (Q1 2026), $882000.0 (Q4 2025), and $1.0 million (Q3 2025), per Business Quant data.